De Novo Design of Protein-Binding Peptides by Quantum Computing

Lars Meuser, Alexandros Patsilinakos, Pietro Faccioli

In silico de novo design can drastically cut the costs and time of drug development. In particular, a key advantage of bottom-up physics-based approaches is their independence from…